GH1, growth hormone 1, 2688

N. diseases: 32; N. variants: 16
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly. 18388193 2008
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human No greater incidence or worsening of cardiac valve regurgitation with somatostatin analog treatment of acromegaly. 18381583 2008
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human Twenty-four hour melatonin pattern in acromegaly: effect of acute octreotide administration. 9186818 1997
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human Congestive heart failure worsening with octreotide in acromegalic patient. 1682667 1991
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human [Effect of repeated injections of sandostatine, with increasing doses, in the treatment of 40 acromegalics. French Group for the study of Sandostatine in Acromegaly]. 3059976 1988
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human Acromegaly in the dog. 6237480 1984
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.400 Biomarker disease CTD_human The history of frequent and excessive administration of a progestational agent suggested that the progestational drug induced the acromegaly.During the monitoring period. soft tissue changes diminished and there was normalization of several factors: plasma growth hormone concentration, response of plasma insulin and glucose to an oral glucose load, and response of plasma glucose hormone to the injection of insulin. 7440347 1980